COVID-19 and personal protective equipment: Treatment and prevention of skin conditions related to the occupational use of personal protective equipment - 23/07/20
Doi : 10.1016/j.jaad.2020.05.032
Seemal R. Desai, MD a, b, ⁎ 
, Carrie Kovarik, MD c, Bruce Brod, MD c, William James, MD c, Matthew E. Fitzgerald, DrPh d, Ave Preston, MSN, RN, CWOCN e, George J. Hruza, MD, MBA f
, Carrie Kovarik, MD c, Bruce Brod, MD c, William James, MD c, Matthew E. Fitzgerald, DrPh d, Ave Preston, MSN, RN, CWOCN e, George J. Hruza, MD, MBA f a Department of Dermatology, The University of Texas Southwestern Medical Center, Dallas, Texas
b Innovative Dermatology, Plano, Texas
c Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania
d American Academy of Dermatology, Rosemont, Illinois
e Department of Nursing, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania
f Department of Dermatology, Saint Louis University, St Louis, Missouri
∗Correspondence and reprint requests to: Seemal R. Desai, MD, 5425 W Spring Creek Pkwy, Ste 265, Plano, TX 750245425 W Spring Creek Pkwy, Ste 265PlanoTX75024
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
| Funding sources: None. |
|
| Conflicts of interest: Drs Desai, Kovarik, Brod, and Hruza are part of the American Academy of Dermatology Ad Hoc Task Force on COVID-19. Authors James, Fitzgerald, and Preston have no conflicts of interest to declare. |
|
| IRB approval status: Not applicable. |
|
| Supplemental material available via Mendeley at y5f78b42s5.1. |
© 2020
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 83 - N° 2
P. 675-677 - août 2020 Retour au numéro
Article précédent
- Cutaneous manifestations related to coronavirus disease 2019 (COVID-19): A prospective study from China and Italy
- Vincenzo De Giorgi, Sebastiano Recalcati, Ziyi Jia, Wei Chong, Renyu Ding, Yunhua Deng, Federica Scarfi, Federico Venturi, Luciana Trane, Alessia Gori, Flavia Silvestri, Xing-Hua Gao, Torello Lotti
- The risk of respiratory tract infections and symptoms in psoriasis patients treated with interleukin 17 pathway–inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic
- Marilyn T. Wan, Daniel B. Shin, Kevin L. Winthrop, Joel M. Gelfand
Bienvenue sur EM-consulte, la référence des professionnels de santé.